Or R - Search Results

1

A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation.

Nagler A, Berger R, Ackerstein A, Czyz JA, Diez-Martin JL, Naparstek E, Or R, Gan S, Shimoni A, Slavin S. Nagler A, et al. Among authors: or r. J Immunother. 2010 Apr;33(3):326-33. doi: 10.1097/CJI.0b013e3181c810b6. J Immunother. 2010. PMID: 20445353 Clinical Trial.

2

A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.

Shimoni A, Avivi I, Rowe JM, Yeshurun M, Levi I, Or R, Patachenko P, Avigdor A, Zwas T, Nagler A. Shimoni A, et al. Among authors: or r. Cancer. 2012 Oct 1;118(19):4706-14. doi: 10.1002/cncr.27418. Epub 2012 Jan 17. Cancer. 2012. PMID: 22252613 Free article. Clinical Trial.

3

Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation.

Nagler A, Ackerstein A, Or R, Naparstek E, Slavin S. Nagler A, et al. Among authors: or r. Blood. 1997 Jun 1;89(11):3951-9. Blood. 1997. PMID: 9166832 Free article. Clinical Trial.

4

Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation.

Or R, Ackerstein A, Nagler A, Amar A, Naparstek E, Varadi G, Kapelushnik J, Samuel S, Pugatsch T, Brautbar C, Slavin S. Or R, et al. J Immunother. 1998 Nov;21(6):447-53. doi: 10.1097/00002371-199811000-00007. J Immunother. 1998. PMID: 9807740 Clinical Trial.

5

Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study.

Slavin S, Ackerstein A, Or R, Shapira MY, Gesundheit B, Askenasy N, Morecki S. Slavin S, et al. Among authors: or r. Cancer Immunol Immunother. 2010 Oct;59(10):1511-9. doi: 10.1007/s00262-010-0878-1. Epub 2010 Jun 20. Cancer Immunol Immunother. 2010. PMID: 20563804 Free PMC article. Clinical Trial.

6

Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.

Slavin S, Morecki S, Weiss L, Or R. Slavin S, et al. Among authors: or r. J Hematother Stem Cell Res. 2002 Apr;11(2):265-76. doi: 10.1089/152581602753658457. J Hematother Stem Cell Res. 2002. PMID: 11983098 Review.

7

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.

Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S, Aker M, Naparstek E, Nagler A, Slavin S. Or R, et al. Blood. 2003 Jan 15;101(2):441-5. doi: 10.1182/blood-2002-02-0535. Epub 2002 Sep 19. Blood. 2003. PMID: 12393604 Free article.

8

Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.

Bitan M, Or R, Shapira MY, Resnick IB, Ackerstein A, Samuel S, Elad S, Slavin S. Bitan M, et al. Among authors: or r. Haematologica. 2005 Aug;90(8):1089-95. Haematologica. 2005. PMID: 16079108 Clinical Trial.

9

Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT).

Slavin S, Or R, Kapelushnik Y, Drakos P, Ackerstein A, Vourka-Karussis U, Weiss L, Nagler A. Slavin S, et al. Among authors: or r. Leukemia. 1992 Nov;6 Suppl 4:164-6. Leukemia. 1992. PMID: 1434823 Clinical Trial.

10

Cutaneous hypersensitivity to co-trimoxazole after autologus bone marrow transplantation and immunotherapy with interferon alpha-2A and interleukin-2.

Mehta J, Nagler A, Ackerstein A, Kapelushnik J, Or R. Mehta J, et al. Among authors: or r. J Assoc Physicians India. 1993 Apr;41(4):235-6. J Assoc Physicians India. 1993. PMID: 8270579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters